The company confirmed the termination of the June 2025 contract in a Friday filing with the Securities and Exchange Commission. Management stated that all outstanding financial obligations to Helena were settled at the time the termination notice was issued. This reversal arrives after a difficult year for the stock, which had fallen 14% prior to the latest surge, despite a modest 2.7% gain during regular market hours.
In section Market Quotes
Advanced Biomed Stock Jumps Following Termination of Helena Agreement
Investors pushed Advanced Biomed shares up 43% to $7.17 in after-hours trading Friday, responding to the company’s decision to scrap a $25 million stock purchase agreement. The move effectively halts a previously arranged deal with Helena Global Investment Opportunities I that would have allowed for significant new equity issuance.
-12-31.jpg?height=635&t=1767210422&width=1200)
Comments (0)
No comments yet. Be the first!